Cel Sci Corporation (CVM)

[GD]

I love FOSCO's DD on OS spread sheets too, but I do not
agree 100% on FOSCO's view of IDMC interims looks, I give
you a most recent example of CLSN, as long as the HR value
does not cross over pre-set bounds which is always higher
than the final HR set for success in SAP, IT-MATTERS's HR
is 0.9, with no issue with safety, IDMC will advise the trial
to continue. Believe me, FOSCO mentioned VICL's PIII for
Melanoma too which I followed years, VICL CEO said the same
thing about DMC's advise to continue on every earnings CC
during the 1.5+ years delay, the final result is HR is 1,
if I remember correctly, the treatment arm OS is little
bid worst than placebo arm. Not trying to change your
mind on CVM, just do not like you calling me a CVM short,
we need good luck with CVM final results, it is truly
a binary event, IMO.